Pharma Veterans

Challenges of Present Times Part I – Blog Post #348 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #348 . Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large . Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here .   There are no two opinions about the fact that these are trying times. I would like to write about it in three heads; organizational challenges, economic challenges, and people challenges.  Organizational Challenges The organizational challenges are unprecedented. They had not faced such issues before. Particularly in Pakistan, where the average age of most businesses is 20-30 years, this is all so very new. We shall see what has changed in this time. Work from Home – many organizations allowed their employees to work from home, those who could. It applied mostly to office staff;

The REMDESIVIR Trials – Blog Post #347 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #347 . Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large . Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here .   Remdesivir is a broad-spectrum antiviral compound developed by Gilead Sciences USA. It is to be given by injection into a vein. The initial studies identified activity against several RNA viruses, however, Remdesivir was not approved for any indication. Remdesivir was originally developed to treat Hepatitis C where Gilead already had great victories with Sofosbuvir and combinations. It was also tested against Ebola virus and Marburg virus disease but was found to be ineffective against all of these. Lately, Remdesivir has been tried in COVID19 in several trials. Here is how results are coming

The RECOVERY Trial – Blog Post #346 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #346 . Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large . Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here .   Randomised Evaluation of COVID-19 Therapy (RECOVERY) is the current hot topic under discussion. In this blog, we look at the basic facts of the trial, its outcomes and the news surrounding it. There is no doubt that RECOVERY Trial has produced exciting and encouraging results. However, the results and context must be understood more clearly. Any rush to take Dexamethasone on your own must be avoided. Even physician-advised improper use should be questioned and discouraged. 1.      I have given below the summary for those who are not familiar with clinical trials and terms. 2.      I have given a